Recruiting Heart Attack Studies in Athens
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.
The main purpose of the study is to evaluate if adding venetoclax to participants receiving cBTKi for the 1L CLL can achieve deep durable remissions of undetectable measurable residual disease \[uMRD ...
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia...
About Heart Attack Clinical Trials in Athens
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Athens, GEORGIA. These studies are seeking a combined 146 participants. Research is being sponsored by Genentech, Inc., Vifor Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Athens — FAQ
Are there heart attack clinical trials in Athens?
Yes, there are 2 heart attack clinical trials currently recruiting in Athens, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Athens?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Athens research site will contact you about next steps.
Are clinical trials in Athens free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Athens studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Athens are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov